fashion -WSS

fashion

author：fashion 2025-09-27 15:58:55 - browse：23626

Moderna's mResvia vaccine — The FDA has approved Moderna’s RSV vaccine for older adults. Moderna

The Food and Drug Administration on Friday approved Moderna’s vaccine to protect older adults against respiratory syncytial virus, or RSV, making this the company’s second licensed product.

The Moderna RSV vaccine, which will be marketed under the name mResvia, was approved for adults 60 and older. It is made using the same messenger RNA platform as Moderna’s other licensed product, its Covid-19 vaccine Spikevax.

“The FDA approval of our second product, mResvia, builds on the strength and versatility of our mRNA platform,” Moderna CEO Stéphane Bancel said in a statement.

STAT+ Exclusive Story

Already have an account? Log in

This article is exclusive to STAT+ subscribers

Unlock this article — plus daily coverage and analysis of the biotech sector — by subscribing to STAT+.

Already have an account? Log in

Monthly

$39

Totals $468 per year

$39/month Get Started

Totals $468 per year

Starter

$30

for 3 months, then $39/month

$30 for 3 months Get Started

Then $39/month

Annual

$399

Save 15%

$399/year Get Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/year Get Started

$300 Annually per user

View All Plans

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： BioMarin wins approval for gene therapy to treat hemophilia A
Next article： Prior authorization reform is both possible and imperative

explore

WSS

Update the Apgar Score to remove skin color

A pediatrician calls for Congress to pass the child tax credit deal

The White House hikes tariffs on plastic syringes made in China

Abbott's new stent may help patients with peripheral artery disease

The White House hikes tariffs on plastic syringes made in China

The inclusion problem at the heart of rehabilitation research

hotspot

fashion

This article is exclusive to STAT+ subscribers

Unlock this article — plus daily coverage and analysis of the biotech sector — by subscribing to STAT+.

Wikipedia

As demand for Covid shots wanes, Moderna seeks its next success

Readout Newsletter: Parkinson's study, Gilead, CG Oncology

Jerome Adams on the need for new antivirals for Covid

FDA endorses new sterilization method for medical devices

Apple is now the first public company to be valued at $3 trillion

CVS is willing to dump 10% of its Medicare Advantage members

BioMarin wins approval for gene therapy to treat hemophilia A

CVS is willing to dump 10% of its Medicare Advantage members

New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum

The White House hikes tariffs on plastic syringes made in China

leisure time

A pediatrician calls for Congress to pass the child tax credit deal

There's an unseen cost to disruptive road

STAT series 'Denied by AI' wins major journalism prizes

Readout Newsletter: Raw milk, Wegovy tests, Eisai and Biogen

Microsoft launches AI tool for clinical documentation through Epic

What causes osteoarthritis? Researchers study link to brain protein

hotspot

explore

explore

focus